AstraZeneca combo diabetes drug Qtrilmet approved in Europe.
AstraZeneca defends diabetes medications in triple lawsuits.
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating
Aurobindo, Glenmark each get U.S. FDA nod for copy of AstraZeneca's diabetes drug An error has occurred.
AstraZeneca is set to invest $26.5 million to establish a new diabetes drug production line at its Taizhou base in China.
Januvia, a diabetes drug from Merck: $113.00, a 79% discount. Farxiga, AstraZeneca's diabetes drug: $178.50, a 68% discount. Entresto, a
FARXIGA is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic Distributed by: AstraZeneca Pharmaceuticals LP
AstraZeneca Will Negotiate With Medicare On Price For Diabetes Drug Drugmaker AstraZeneca tells Politico that it plans to participate in
CDSCO approves AstraZeneca's anti-diabetic drug Dapagliflozin with additional indications AstraZeneca India has received the Central Drugs
Comments